- Home
- CHRS vs NEGG Comparison
CHRS vs NEGG Comparison
Compare CHRS & NEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- NEGG
- Stock Information
- Founded
- CHRS 2010
- NEGG 2001
- Country
- CHRS United States
- NEGG United States
- Employees
- CHRS N/A
- NEGG 932
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- NEGG Other Specialty Stores
- Sector
- CHRS Health Care
- NEGG Consumer Discretionary
- Exchange
- CHRS Nasdaq
- NEGG Nasdaq
- Market Cap
- CHRS 191.3M
- NEGG 171.3M
- IPO Year
- CHRS 2014
- NEGG 2010
- Fundamental
- Price
- CHRS $1.16
- NEGG $0.44
- Analyst Decision
- CHRS Strong Buy
- NEGG
- Analyst Count
- CHRS 4
- NEGG 0
- Target Price
- CHRS $5.38
- NEGG N/A
- AVG Volume (30 Days)
- CHRS 2.4M
- NEGG 1.1M
- Earning Date
- CHRS 03-12-2025
- NEGG 08-29-2024
- Dividend Yield
- CHRS N/A
- NEGG N/A
- EPS Growth
- CHRS N/A
- NEGG N/A
- EPS
- CHRS N/A
- NEGG N/A
- Revenue
- CHRS $304,340,000.00
- NEGG $1,391,833,000.00
- Revenue This Year
- CHRS $2.47
- NEGG $6.01
- Revenue Next Year
- CHRS N/A
- NEGG N/A
- P/E Ratio
- CHRS N/A
- NEGG N/A
- Revenue Growth
- CHRS 44.19
- NEGG N/A
- 52 Week Low
- CHRS $0.66
- NEGG $0.39
- 52 Week High
- CHRS $2.87
- NEGG $1.32
- Technical
- Relative Strength Index (RSI)
- CHRS 38.01
- NEGG 43.37
- Support Level
- CHRS $1.03
- NEGG $0.39
- Resistance Level
- CHRS $1.39
- NEGG $0.49
- Average True Range (ATR)
- CHRS 0.14
- NEGG 0.04
- MACD
- CHRS -0.03
- NEGG 0.00
- Stochastic Oscillator
- CHRS 14.04
- NEGG 26.45
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.